Treatment allocation in patients with hepatocellular carcinoma: Need for a paradigm shift?
Liver Cancer International · 2022
DOI: 10.1002/lci2.42 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Cancer International, 2022. Verfasst von Alessandro Vitale und 4 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vitale, A., Finotti, M., Trevisani, F., Farinati, F., & Giannini, E. G. (2022). Treatment allocation in patients with hepatocellular carcinoma: Need for a paradigm shift?. Liver Cancer International. https://doi.org/10.1002/lci2.42
Vancouver
Vitale A, Finotti M, Trevisani F, Farinati F, Giannini EG. Treatment allocation in patients with hepatocellular carcinoma: Need for a paradigm shift?. Liver Cancer International. 2022. doi:10.1002/lci2.42
BibTeX
@article{Vitale2022,
author = {Vitale, Alessandro and Finotti, Michele and Trevisani, Franco and Farinati, Fabio and Giannini, Edoardo G.},
title = {Treatment allocation in patients with hepatocellular carcinoma: Need for a paradigm shift?},
journal = {Liver Cancer International},
year = {2022},
doi = {10.1002/lci2.42}
}
EUVIMED